Addressing this issue will require substantial examination of patients for both polySer expression and tau pathology, but highlights the possibility that developing our understanding of the links between polySer and tau can provide insight into disease mechanisms beyond primary tauopathies. This evidence concerns the gene MAPT and tauopathy.